Search

Search Constraints

You searched for: Author/Creator Vivas, Assumpta

Search Results

1. [P1–141]: EXPLORING APOE GENOTYPE EFFECTS ON AD RISK AND BETA‐AMYLOID BURDEN IN INDIVIDUALS WITH SUBJECTIVE COGNITIVE DECLINE: THE FACEHBI STUDY RESULTS. (1st July 2017)

2. [P3–233]: CORRELATIONS BETWEEN PLASMA AND BRAIN BETA‐AMYLOID LEVELS IN INDIVIDUALS WITH SUBJECTIVE COGNITIVE DECLINE: THE FUNDACIÓ ACE HEALTHY BRAIN INITIATIVE (FACEHBI). (1st July 2017)

3. BIOFACE: A prospective study of risk factors, cognition and biomarkers in a cohort of individuals with early‐onset mild cognitive impairment at Fundació ACE. (31st December 2021)

4. Brain structural changes in subjective cognitive decline: A whole brain surface‐based analysis in the FACEHBI cohort. (1st February 2022)

5. Brain structural changes in subjective cognitive decline: A whole brain surface‐based analysis in the FACEHBI cohort. (December 2021)

6. Exploring APOE genotype effects on Alzheimer's disease risk and amyloid β burden in individuals with subjective cognitive decline: The FundacioACE Healthy Brain Initiative (FACEHBI) study baseline results. Issue 5 (20th November 2017)

7. Metabolic syndrome impact on cognitive composites domain scores and on white matter hyperintensities in subjective cognitive decline: The FACEHBI Cohort. (31st December 2021)

8. P1‐321: White Matter Microstructure Disruption Could Be an Early Phenomenon in The Pathophysiology of Preclinical Alzheimer's Disease: FundaciÓ ACE Healthy Brain Initiative. (1st July 2016)

9. P1‐428: APOE STATUS MODULATES BRAIN PATTERNS OF AMYLOID DISTRIBUTION IN INDIVIDUALS WITH SUBJECTIVE COGNITIVE DECLINE (SCD) FROM THE FACEHBI STUDY. (1st July 2006)

10. P2‐141: FundaciÓ ACE Healthy Brain Initiative: A Study of Cognition and Biomarkers in Individuals with Subjective Cognitive Decline. (1st July 2016)